Eksponeringen af O- desmethyl- metabolitten var forhøjet adskillige gange hos patienter med moderat og alvorlig nedsat nyrefunktion.
The exposure of the O-desmethyl metabolite was several-fold increased in patients with moderate and severe renal impairment.